| BHT | butylated hydroxytoluene |
| BPD | benzoporphyrin derivative monoacid |
| CHEMS | cholesteryl hemisuccinate |
| CMAs | critical material attributes |
| CMC | critical micelle concentration |
| CPPs | critical process parameters |
| CQAs | critical quality attributes |
| Cryo-TEM | cryogenic transmission electron microscopy |
| DLS | dynamic light scattering |
| DMPC | 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
| DOPC | 1,2-dioleoyl-sn-glycero-3-phosphocholine |
| DOPE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine |
| DOTAP | 1,2-dioleoyl-3-trimethylammonium-propane |
| DPPC | dipalmitoylphosphatidylcholine |
| DPPG | 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol |
| DSC | differential scanning calorimetry |
| DSPC | 1,2-distearoyl-sn-glycero-3-phosphocholine |
| DSPE | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine |
| DSPG | 1,2-distearoyl-sn-glycero-3-phospho-(1′-rac-glycerol), sodium salt |
| EGFR | epidermal growth factor receptor |
| EPC | egg phosphatidylcholine |
| EPO | erythropoietin |
| FOP | (3-Fluoro-4-((octyloxy)carbonyl)phenyl)boronic acid |
| HA2 | hemagglutinin-2 |
| HPLC | high-performance liquid chromatography |
| HSPC | hydrogenated soy phosphatidylcholine |
| mPEG2000-DSPE | methoxy polyethylene glycol–distearoyl phosphatidylethanolamine |
| MPS I | mucopolysaccharidosis Type I |
| MSPC | 1-myristoyl-2-stearoyl-sn-glycero-3-phosphocholine |
| MTX | methotrexate |
| NLCs | nanostructured lipid carriers |
| PAMAM | poly(amidoamine) |
| PC | phosphatidylcholine |
| PDI | polydispersity index |
| PE | phosphatidylethanolamine |
| PLGA | poly(lactic-co-glycolic acid |
| PI | phosphatidylinositol |
| QbD | quality by design |
| SLNs | solid lipid nanoparticles |
| TEM | transmission electron microscopy |
| TNF-α | tumor necrosis factor-α |